1. Moderna heads to the FDA for an EUA for its COVID-19 vaccine — AstraZeneca plans extra trial for its COVID vaccine — Biogen bets $1.5B on Sage's failed depression drug — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Vascular

Discussion in 'Teleflex Medical' started by anonymous, Jan 11, 2018 at 3:43 PM.

  1. anonymous

    anonymous Guest

    Can anyone fill me in on the vascular business? Would appreciate any info.
    Thank you
     
  2. anonymous

    anonymous Guest

    here’s some input-run far far away! Teletard is a joke of a company!
     
  3. anonymous

    anonymous Guest

    They also hit an all time high with their stock last week and in a five year period went from $80 per share to $280. The joke is on the uneducated.
     
  4. anonymous

    anonymous Guest

    and how much of that stock did they give to their reps? Jokes on the most underpaid medical device sales reps in the industry. Enjoy being a philanthropist.
     
  5. anonymous

    anonymous Guest

    teleflex is a Medreps best place to work . Wonder how much that cost them cause they suck
     
  6. anonymous

    anonymous Guest

    haha teletards pushing minicrap. Stryker dropped that product like they were playing hot potato
     
  7. anonymous

    anonymous Guest

    The vascular division is, by far, the best division in Teleflex. That being said, Teleflex as a whole is the worst company in the Medical Device arena. The pay is terrible, they micro manage, there is no innovation and there is no accountability from the top. The quotas are nearly unattainable and expectations are ridiculous. Did I mention the fact that there are never any new products. Do yourself a favor and look at other opportunities. Hope this answered your question